UUnilabs is an international diagnostics provider that delivers medical testing and imaging services for healthcare providers, hospitals, and patients across Europe. Its offering covers laboratory testing, radiology imaging, and pathology analyses, with results used to guide treatment decisions. The company operates by collecting patient samples, running standardized tests in its labs, performing imaging studies, and delivering clear diagnostic reports to clinicians, all under strict quality control to ensure accuracy. What sets Unilabs apart is its extensive geographic reach, long history in diagnostics, and a strong emphasis on quality and continuous improvement, enabling integrated, reliable services across multiple countries. The company’s goal is to deliver precise, timely diagnostic information to support effective patient care and treatment decisions.
Work here?Claim your company
Industries
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Coppet, Switzerland
Founded
1987
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Unilabs Brand Guidelines: Geneva 1987, Capio & Four ways to diagnose. October 28, 2026 Editorial Team Save this: Brand Guidelines · Field Guide Unilabs Brand Guidelines A Geneva laboratory, a borrowed English slogan and four ways to diagnose. Two constants: a lake Geneva blue, night lab and reagent teal palette and a Plain clinical sans register. Abstract homage - not a Unilabs asset or mark; no logo or wordmark is reproduced. Unilabs starts in Geneva with branches in Bern and St. Gallen 1987 Shares quoted on the Swiss exchange 1997 The Swedish group buys Unilabs and merges its diagnostics arm 2007 Imaging group CMDI joins Unilabs 2019 A Geneva laboratory company. Geneva, Bern and St. Gallen, 1987. Unilabs has been a Geneva business from the start. German Wikipedia says the company was founded in Geneva in 1987, with branches in Bern and St. Gallen, and that its headquarters are still in the city. The Swiss financial site allnews.ch, writing on 14 November 2019, called it "the Geneva diagnostics laboratory" and gave the same founding year. The company's own website says that for more than three decades, since its founding in Switzerland, Unilabs has worked to support healthcare through diagnostic insight, scientific expertise and innovation. The early growth crossed the Alps quickly. German Wikipedia says a site in Turin opened in 1989, which started the company's presence in Italy, and that the international push continued the following year with the purchase of three laboratories in Spain. After that, it says, Unilabs kept expanding through acquisitions and new sites both in Switzerland and abroad. By the middle of the next decade the company had a clear public face. The Geneva daily Le Temps profiled it on 5 February 2005, describing Edgard Zwirn, who was born in Belgium, as the boss and co-owner of the Geneva company and noting that two families, the Zwirn and Gherardi families, held the controlling shares. The paper said Unilabs had been quoted on the stock exchange since 1997, and that its growth strategy, in Switzerland but above all in France and Italy, rested on the belief that Europe's many small medical laboratories would consolidate into larger networks. Zwirn made that argument by looking west. He told Le Temps that what happened in the United States tended to arrive in Europe about twenty years later, and he pointed to the American groups Quest Diagnostics and LabCorp as examples of where the business had gone there. In Switzerland, the paper said, Unilabs had recently bought several laboratories in the regions around Bern and Lausanne, while Zwirn told financial analysts that the European expansion would follow once national rules on grouping laboratories changed. Colour. A Swedish buyer, a delisting and new owners. The ownership changed in 2007. allnews.ch said Unilabs was bought that year by the Swedish healthcare group Capio, which took it off the Swiss stock exchange. German Wikipedia adds that the company, listed on the SWX Swiss Exchange until the middle of March 2008, merged in the autumn of 2007 with the diagnostics business that had been carved out of the Capio group. The name that came through the merger was Unilabs, and Geneva remained the headquarters. Two more ownership changes followed. German Wikipedia says the European Commission cleared the takeover of Unilabs by funds advised by an investment firm in 2017. In December 2021, it says, a Danish family-owned holding company agreed to acquire the business, and Unilabs has been wholly owned by that holding company since 2022. Through each of these deals the company kept both its name and its Geneva base. Spain shows how the group grew in the years between. The Spanish trade publication Alimarket reported on 28 October 2019 that the Unilabs group, "of Swiss origin" and specialised in diagnostic services, had strengthened its presence in Spain by buying CMDI, a Spanish diagnostic imaging group headed by a company based in Cádiz, with centres across many of the country's regions. The publication said the purchase fitted Unilabs's plan to grow in Spain and to turn CMDI into a reference name in the Spanish radiology market by widening its range of services and growing its teleradiology business. Unilabs's executive chairman told Alimarket that the company was "very happy" to welcome CMDI to the Unilabs family, and that the deal marked its entry into the radiology segment in Spain. The services have widened with the map. German Wikipedia lists four areas today: clinical laboratory diagnostics; medical imaging, including MRI, CT, X-ray and ultrasound; pathology and histopathology; and genetic and molecular diagnostics, offered in European and Middle Eastern markets. The company's own website adds the Unilabs Academy, a teleradiology service and Unilabs Pharma Solutions for partners in the pharmaceutical and contract-research fields. Lake Geneva Blue Reagent Teal Slide Grey Typography. A plain name, a borrowed slogan and four disciplines. Companies that sell to other businesses, hospitals, farms, builders and exam candidates rarely need to win a customer at a glance. Their buyers compare specifications, sign long contracts and come back year after year, so the brand works more like a signature on a promise than a poster. Many of these names began as a founder's surname, a home town or a county, or a pair of companies joined by merger; others are coined words built to travel across languages and markets. Either way the name is usually kept short and set in a plain, sturdy sans or a simple capital wordmark, because it has to sit on a report cover, a lab form, a seed bag, a test-centre door and a website without looking out of place. Colour carries much of the load. A corporate blue, green, red or yellow has to survive on painted machinery and trucks, on factory walls and site hoardings, on printed results and certificates, and on small screens, so it tends to be one strong tone backed by greys and white rather than a broad palette. The tone of voice is steady and practical: these identities set out to signal reliability, care and consistency rather than excitement or fashion. For designers, the lesson is that a business-to-business brand earns trust through repetition, with the same mark, colour and lettering appearing in the same way wherever a customer meets it. Plain clinical sans - after the Roboto type on the Unilabs website. (Specimen set in Roboto, a sans STAND-IN; NOT the Unilabs logo or any Unilabs lettering.) Plain clinical sans · the register Lake Geneva blue, night lab and reagent teal · the palette A Geneva laboratory, a borrowed English slogan and four ways to diagnose · the signature Unilabs. From "new momentum" to four ways to diagnose. The name has carried the brand for almost four decades. Unilabs was a Geneva company when Le Temps profiled it in 2005, the name survived the 2007 merger with the Capio diagnostics arm, and in 2019 both allnews.ch and Alimarket were still writing about the group as Unilabs. In the early 2000s the company spoke in English. Le Temps said the phrase "Taking advantage of a new momentum" had become both the slogan and a pillar of Unilabs's commercial plan from 1997, the year the listing began, and the paper offered a French translation for its readers. Zwirn told the paper that from talking so much about new momentum people had started to stop taking the company seriously, but he insisted the moment had come. Today's language is calmer and more clinical. The title of the company's home page reads "Powering health by supporting healthcare decisions every day", and its about page uses the variation "Powering health by supporting informed decisions every day". The service pages are organised under the line "Four ways to diagnose, one way to care", which groups the business into clinical laboratory testing, radiology, pathology and genetics, and the about section opens with "Health starts with you and continues with us". The site addresses four audiences in turn: healthcare professionals, hospitals and institutions, pharmaceutical and research partners, and patients and citizens. The typography follows the same plain register. The Unilabs website is set in Roboto, the Google sans, the same family used here for the specimen. For a design guide, Unilabs shows how a laboratory group can keep one plain name through several owners and let its slogans shift from market momentum to everyday decisions. Compare SYNLAB, a German laboratory group, and Cerba HealthCare, a French one. For this guide Made Good Designs use lake Geneva blue, night lab and reagent teal with a sans, an unofficial interpretation; no product or logo is reproduced. Explore & save. Keep Unilabs's identity on hand - save it to a board in the Made Good inspiration library. Unilabs identity set. Pin the Unilabs lake Geneva blue, night lab and reagent teal palette and the Plain clinical sans register to your own board. Core Palette Plain clinical sans Source & notes. Sources: allnews.ch (14 November 2019); Alimarket (28 October 2019); Le Temps (5 February 2005); German Wikipedia (Unilabs); Unilabs website. No official brand hex is published, so the tones here are an unofficial interpretation, and no product or mark is reproduced.
Growth capital for AI & Services companies. Backing founders who have built without significant institutional support.
Circle Health Group expands into UK laboratory operations. Circle Health Group (Circle) has expanded into laboratory operations across the UK through the acquisition of selected laboratory operations from Unilabs. The operations, which have transferred to Circle, provide pathology, histopathology, blood sciences, microbiology and specialist diagnostic services to more than 90 external healthcare clients. The move will allow Circle to integrate laboratory services more closely with its hospital network, with the group aiming to improve collaboration between clinicians and laboratory specialists while increasing operational capacity and responsiveness. Circle Health Group is part of global healthcare group PureHealth and will draw on the expertise of its laboratory subsidiary, PureLab. The company operates more than 150 laboratories and processes more than 25 million tests annually, with capabilities including automation and AI-enabled diagnostics. Paul Manning, CEO of Circle Health Group, said integrating diagnostics with its hospitals would create a more connected model of care. "Integrating diagnostics more closely with our hospitals allows us to deliver a more connected model of care," he said. "It strengthens collaboration between clinicians and laboratory specialists, improves operational responsiveness and provides a strong foundation to support our continued growth." Circle said the laboratory network would continue to prioritise its existing external healthcare clients, while also providing capacity for new customers. The group said the expansion formed part of its multi-year growth strategy, with investment planned in laboratory equipment, technology and scientific and clinical staff. The acquisition will also enable Circle to expand diagnostic services across its hospital network, with the company aiming to improve access to testing and reduce turnaround times. No items found
WHOOP has partnered with Unilabs to launch Advanced Labs in the UAE, enabling members to integrate clinical blood biomarker data with their continuous health tracking. The partnership allows WHOOP members to book a 65-biomarker panel through Unilabs for 733 AED, with testing available at Unilabs centres or via home collection. Members can upload lab results directly to the WHOOP app, where they receive personalised guidance from WHOOP Coach that contextualises biomarkers alongside recovery, sleep and daily behaviours. The integration provides long-term health trend analysis in one platform. Founded in 2012, WHOOP has raised over $400 million and ships to 56 markets worldwide. Unilabs is an international diagnostic services provider operating across four continents, serving nearly 100 million people annually.
Unilabs Middle East and EMANT society launch kidney health awareness and screening campaign. Campaign to kick off in collaboration with Emirates Health Services (EHS) and the National Programme for Organ and Tissue Donation and Transplantation, "Hayat" * Running for five months, the drive aims to reach 10,000 participants across the UAE Unilabs Middle East, a leading diagnostic service provider, has joined forces with the the Emirates Medical Association, Nephrology and Transplantation Society (EMANT) to launch the Kidney Health Awareness and Screening Campaign. The campaign aims to raise awareness about the importance of kidney health and encourage early detection by offering free screening services throughout the campaign period. It comes as part of community initiatives and in line with the UAE's national policy to promote healthy lifestyles. In collaboration with Emirates Health Services (EHS) and "Hayat," the National Programme for Organ and Tissue Donation and Transplantation, the campaign will run for five months, reaching more than 10,000 people across the UAE. Additional partners from both government and private sectors are expected to come on board to expand the campaign's reach and impact. The campaign is proudly supported by leading pharmaceutical companies, including Boehringer Ingelheim, Novartis, Vantive, and CSL., whose commitment to advancing community health and preventive care continues to drive meaningful impact across the UAE. It is set to make a wide-reaching impact by promoting preventive healthcare and supporting national health priorities in the UAE. Key activities include open days for basic laboratory testing at multiple locations, alongside educational workshops, school exhibitions, and interactive community events designed to engage diverse audiences and raise awareness across all age groups. Dr. Shaikha Rashid Obaid Ali, Consultant Internal Medicine & Nephrology, Sheikh Khalifa Medical City Ajman, and Scientific Committee Chairperson, Emirates Medical Association Nephrology and Transplantation Society (EMANT), said: "The Kidney Health Awareness and Screening Campaign represents an important milestone in our ongoing mission to promote kidney health across the UAE. By focusing on prevention, early detection, and community education, we aim to reduce the rising burden of chronic kidney disease and encourage individuals to take proactive steps in safeguarding their health. At EMANT, our vision is to advance kidney health through awareness, research, and collaboration, ensuring that every member of our community has access to the knowledge and support needed for early intervention and better outcomes." The initiative aims to empower individuals to take charge of their health through early detection and to provide free screening services for those most at risk. EMANT official urged members of the public to participate in the campaign, fostering a healthier and more informed society. Dr. Ali Bayoumi, Medical Director SBU Genetics Unilabs Global, and Medical Director Middle East Cluster Said: "Our partnership with EMANT falls under the umbrella of our Year of Community initiatives and reflects our shared belief that preventive healthcare and early diagnosis are key pillars of building a healthier society. We are proud to contribute to this vital campaign that will benefit thousands across the UAE." He added, "Unilabs is committed to playing a key role as a trusted diagnostics partner, leveraging its extensive expertise and advanced laboratory capabilities to deliver accurate and timely results. This would support early detection and help take the right health decisions, in line with the national policy to promote healthy lifestyles." Unilabs and the Emirates Medical Association, Nephrology and Transplantation Society call on all members of the community, particularly those with chronic health conditions, to participate in the campaign's free events and screenings. They also urge healthcare professionals to help amplify the message by raising awareness within their clinics and facilities as part of a collective effort to achieve the campaign's goal of screening 10,000 participants. About Unilabs Unilabs is a leading global provider of diagnostic services, offering a comprehensive package of laboratory, pathology, and genetic solutions across four continents. With more than 13,000 specialists in 14 countries, Unilabs leverages cutting-edge digital technologies in its laboratories to enhance the lives of nearly 100 million people each year. Boasting over 30 years of experience in pharmaceutical solutions, Unilabs specialises in clinical trials conducted within environments regulated by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Unilabs: For more information, please contact [email protected] Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an "as is" and "as available" basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release. The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk. To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Coppet, Switzerland
Founded
1987
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs